Methyclothiazide
A thiazide diuretic used to treat high blood pressure and fluid retention (edema) caused by heart failure, kidney disease, or liver disease. It works by increasing urine output to reduce fluid and lower blood pressure.
Berat Molekul
360,2000 g/mol
LogP
1,40
TPSA
126,00 Ų
Lipinski RO5
Lulus
Area Terapeutik
Mekanisme Kerja
Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.
Struktur 2D
Cite this structure
Embed this structure
SMILES
CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O
InChI
InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)
Molecular Formula
C9H11Cl2N3O4S2
HBD / HBA
2 / 7
Ikatan yang Dapat Dirotasi
2
Atom Berat
20
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
A thiazide diuretic used to treat high blood pressure and fluid retention (edema) caused by heart failure, kidney disease, or liver disease. It works by increasing urine output to reduce fluid and lower blood pressure.
Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.
Yes, Methyclothiazide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1577. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4121. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="methyclothiazide"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/methyclothiazide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/methyclothiazide/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/methyclothiazide/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="methyclothiazide"></drugfyi-drug>